Schizophrenia and other psychotic disorders are serious and debilitating mental illnesses that incur substantial suffering for patients and major challenges to our health care system. The clinical high-risk (CHR) prodromal phase is the period prior to the onset of psychosis when clinical symptoms gradually emerge and function declines. The presence of a CHR syndrome in young adults is associated with heightened risk (~30%) for the later development of psychosis. The North American Prodrome Longitudinal Study (NAPLS) and other CHR studies have made substantial progress towards predicting psychosis, and in showing an accelerated reduction in prefrontal cortex (PFC) gray matter (GM) density in CHR converters from pre- to post-psychosis onset, but the mechanisms driving conversion remain elusive, partly because no studies include repeated measures prior to the onset of psychosis. In NAPLS2, we found that disrupted resting-state (rs) thalamo- cortical functional connectivity prior to psychosis predicts conversion and correlates with rate of GM decline, but we do not know if rs-dysconnectivity is progressive during the prodrome. Furthermore, in NAPLS2, plasma markers of pro-inflammatory cytokines at baseline predicted the rate of GM loss in converters;these same markers also correlated with rs-dysconnectivity. We do not yet know whether these inflammatory markers drive the changes in brain structure/function or are consequences of these changes. Similarly, higher levels of cortisol, and lower mismatch negativity predicted psychosis and the rate of PFC GM decline and were correlated with each other and with measures of rs-connectivity and cytokines. This application is a competitive renewal for a nine-site, longitudinal study aimed at identifying the brain processes underlying the progression of the clinical syndromes that characterize the psychosis prodrome. The goals are: 1) to determine the pre-onset trajectories of GM decline and disrupted resting-state brain connectivity in CHR individuals who develop psychosis using MRI, and 2) to identify inflammatory and plasticity mechanisms associated with transition to psychosis. Over a two-year period, the study will repeatedly measure these indicators, and at the same time examine changes in physiological indices of brain function, social and cognitive functioning, and symptom progression. The multi-site collaboration will follow large CHR (n= 378) and demographically matched comparison (n= 162) samples that will undergo comprehensive assessments of biological and behavioral changes. This approach will answer important questions about the origins of the brain changes that give rise to psychosis and will provide insights into likely approaches to halting or mitigatig the pathological process and advance our understanding of risk prediction, both critical steps in prevention.

Public Health Relevance

Psychotic disorders typically have their clinical onset in young adulthood, and often derail educational progress and interfere with the acquisition of social skill required for independent adult functioning. There is a broad cost to society that accrues on a personal level in the loss of adult productivity and healthy maturation, and on a socioeconomic level in rising mental health care costs. Elucidating the underlying neurobiological processes in early psychosis will move us closer to targeted preventive interventions that have the potential to halt or ameliorate this neuropathological process and improve the outcome of this vulnerable population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01MH081928-06A1
Application #
8884972
Study Section
Special Emphasis Panel (ZMH1-ERB-D (06))
Program Officer
Rumsey, Judith M
Project Start
2007-12-01
Project End
2019-06-30
Budget Start
2014-09-25
Budget End
2015-06-30
Support Year
6
Fiscal Year
2014
Total Cost
$808,262
Indirect Cost
$264,330
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Forsyth, Jennifer K; McEwen, Sarah C; Gee, Dylan G et al. (2014) Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage 97:41-52
Woodberry, Kristen A; Serur, Rachael A; Hallinan, Sean B et al. (2014) Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth. Schizophr Res 158:45-51
Meyer, Eric C; CarriĆ³n, Ricardo E; Cornblatt, Barbara A et al. (2014) The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull 40:1452-61
Del Re, E C; Bergen, S E; Mesholam-Gately, R I et al. (2014) Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds. Transl Psychiatry 4:e346
Marshall, Catherine; Denny, Erin; Cadenhead, Kristin S et al. (2014) The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Res 219:506-12
Saleem, Majid M; Stowkowy, Jacqueline; Cadenhead, Kristin S et al. (2014) Perceived discrimination in those at clinical high risk for psychosis. Early Interv Psychiatry 8:77-81
Woods, Scott W; Walsh, Barbara C; Addington, Jean et al. (2014) Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res 158:69-75
Li, Huijun; Friedman-Yakoobian, Michelle; Min, Grace et al. (2013) Working with Asian American youth at clinical high risk for psychosis: a case illustration. J Nerv Ment Dis 201:484-9
Walder, Deborah J; Holtzman, Carrie W; Addington, Jean et al. (2013) Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophr Res 144:43-50
Woods, Scott W; Addington, Jean; Bearden, Carrie E et al. (2013) Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res 148:99-104

Showing the most recent 10 out of 17 publications